Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × copanlisib × 1 year × Clear all

Sponsor

Conditions

Neoplasm Metastasis 5 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Breast Neoplasms 3 Ovarian Neoplasms 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Endometrial Neoplasms 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Spinocerebellar Degenerations 1 Neoplasms 1 Mycosis Fungoides 1 Metastatic Castration-resistant Prostate Cancer 1 Malignant Solid Neoplasm 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 Disease Progression 1 Colonic Neoplasms 1

Interventions

fludarabine 18 Whole-Body Irradiation 15 Cyclophosphamide 15 ruxolitinib 14 fludarabine phosphate 12 Tacrolimus 11 Specimen Handling 11 Mycophenolic Acid 11 Biopsy 10 Azacitidine 10 venetoclax 8 Peripheral Blood Stem Cell Transplantation 8 Melphalan 8 Cytarabine 8 Busulfan 7 Injections 6 Stem Cell Transplantation 5 Sirolimus 5 Daunorubicin 5 CPX-351 5 luspatercept 4 itacitinib 4 fedratinib 4 decitabine and cedazuridine drug combination 4 Liposomes 4 Granulocyte Colony-Stimulating Factor 4 ivosidenib 3 Thiotepa 3 Methotrexate 3 Cyclosporine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡